## Clinical Context The patient presents with the classic triad of **malignant hyperthermia (MH)**: 1. **Muscle rigidity** (rigid abdominal muscles) 2. **Hypermetabolic state** — tachycardia, hypotension, flushed skin 3. **Rising end-tidal CO₂** (6.5 kPa) — hallmark sign reflecting uncontrolled skeletal muscle hypermetabolism **Note:** MH is triggered by **volatile halogenated anaesthetics** (e.g., halothane, sevoflurane, desflurane) and **succinylcholine** (a depolarizing neuromuscular blocker). Vecuronium is a **non-depolarizing** agent and does NOT trigger MH. Thiopental alone is also not a known MH trigger. The question stem implies MH susceptibility in the context of the overall anaesthetic exposure. ## Muscle Biopsy with Contracture Testing: Most Specific Investigation **Key Point:** The **In Vitro Contracture Test (IVCT)** — performed on a fresh muscle biopsy specimen — is the **gold standard and most specific investigation for confirming MH susceptibility**, as defined by the European Malignant Hyperthermia Group (EMHG) and North American MH Registry (NAMHR). ### How the IVCT Works | Step | Detail | |---|---| | **Specimen** | Fresh skeletal muscle biopsy (usually vastus lateralis) | | **Procedure** | Muscle strips exposed to halothane and caffeine in vitro | | **Positive result** | Abnormal contracture response at defined thresholds | | **Sensitivity** | ~99% (European protocol) | | **Specificity** | ~93.6% (European protocol) | **High-Yield:** The IVCT directly tests the pathophysiological mechanism of MH — abnormal ryanodine receptor (RYR1) function causing uncontrolled Ca²⁺ release from the sarcoplasmic reticulum. No other test directly assesses this mechanism. ## Why Muscle Biopsy/Contracture Testing is the Most Specific The question asks for the **most specific** investigation for **confirming the suspected diagnosis** of MH. Specificity refers to the ability to definitively confirm the diagnosis, not merely support it acutely: - **IVCT is the only test that directly confirms MH susceptibility** at the cellular/molecular level - ABG, CK, and myoglobin are **non-specific** — they reflect rhabdomyolysis and hypermetabolism from many causes (sepsis, neuroleptic malignant syndrome, thyroid storm, etc.) - Genetic testing for RYR1/CACNA1S mutations is complementary but less sensitive than IVCT ## Comparison of Investigations | Investigation | Role | Specificity for MH | |---|---|---| | **Muscle biopsy + IVCT** | Gold standard confirmatory test | **Highest (~93.6%)** | | **ABG with electrolytes** | Rapid intraoperative monitoring; guides acute management | Low — findings non-specific (seen in sepsis, NMS, etc.) | | **Serum CK + myoglobin** | Confirms rhabdomyolysis post-hoc | Very low — non-specific marker | | **Urine myoglobin** | Detects myoglobinuria | Very low — non-specific | **Clinical Pearl:** While **ABG is the most useful investigation in the acute intraoperative setting** (rapid, actionable, guides dantrolene therapy), the question specifically asks for the **most specific** investigation for **confirming** the diagnosis — which is unambiguously the **muscle biopsy with in vitro contracture testing (IVCT)**, per Harrison's Principles of Internal Medicine and Miller's Anesthesia. ## Key Reference - **Miller's Anesthesia (9th ed.):** IVCT is the definitive diagnostic test for MH susceptibility - **Harrison's Principles (21st ed.):** Muscle biopsy with caffeine-halothane contracture test is the gold standard for MH confirmation - **EMHG Protocol:** Sensitivity 99%, Specificity 93.6% for IVCT **Mnemonic:** **MH GOLD** = **Muscle biopsy, Halothane/caffeine contracture test, Only specific test, Linked to RYR1, Definitive confirmation**
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.